2 result(s) displayed (1 - 2 of 2):

Linklaters' Schmidt on Pfizer-Wyeth review (from Corporate Dealmaker)

The approval by U.S. antitrust regulators of Pfizer Inc.'s (NYSE:PFE) acquisition of Wyeth is an outlier of how merger reviews will be conducted under the Obama administration. That's according to Jeffrey Schmidt, a partner with Linklaters and a former director of the Federal Trade Commission's office of competition under President...

Posted on November 6, 2009 3:50 PM

Linklaters' Schmidt on antitrust merger reviews (from Corporate Dealmaker)

Candidate Barack Obama talked plenty during last year's presidential campaign about the need for more aggressive antitrust merger reviews. Have the Federal Trade Commission and the Department of Justice delivered? We put the question to Jeffrey Schmidt, a partner in the New York office of Linklaters and a former director...

Posted on November 5, 2009 6:29 AM